This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 94/8/1059    most recent 01.RES.0000125296.14014.17v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nelson, T. J. Articles by Misra, R. P. Search for Related Content PubMed PubMed Citation Articles by Nelson, T. J. Articles by Misra, R. P. Related Collections Physiological and pathological control of gene expression Cardiac development Other Vascular biology

(Circulation Research. 2004;94:1059.)
© 2004 American Heart Association, Inc.

Molecular Medicine

Conserved Enhancer in the Serum Response Factor Promoter Controls Expression During Early Coronary Vasculogenesis

Timothy J. Nelson, Stephen A. Duncan, Ravi P. Misra

From the Departments of Biochemistry (T.J.N., R.P.M.), Cell Biology, Neurobiology, and Anatomy (S.A.D.), Medical College of Wisconsin, Milwaukee, Wis.

Correspondence to Ravi P. Misra, PhD, Department of Biochemistry Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail rmisra{at}mcw.edu

Serum response factor (SRF) is a transcription factor required for mesoderm formation in the developing mouse embryo that is important for myogenic differentiation, including notably, the differentiation of the proepicardial organ (PEO) into coronary vascular cells during early development. To identify regulatory sequences that control SRF expression during early mouse development, we used a novel transgenic approach to study the role of conserved noncoding DNA sequences (CNCS) in the SRF gene. Embryonic stem (ES) cells containing a targeted single-copy of putative SRF regulatory sequences were used to directly generate transgenic embryos by tetraploid aggregation. Because the ES cell-derived targeted embryos are genetically equivalent, except for the putative regulatory sequence of interest, differences in transgene expression can be attributed directly to these sequences. Using this approach, we identified an E-box/Ets containing 270-bp cis-acting module in the SRF promoter that mediates expression in the PEO. Reporter transgenes containing this module express in derivatives of the PEO that give rise to the coronary vasculature, but do not express in the PEO-derived epicardium. These results are the first reported in vivo analysis of SRF regulatory elements that control expression during early development. Using this reporter module and this approach, it should be possible to begin to elucidate molecular mechanisms involved in the differentiation of coronary vasculature progenitor cells, as well as identify additional SRF regulatory elements important during mammalian development.

Key Words: serum response factor • gene targeting • transcriptional regulation • proepicardial organ • coronary vascular development

This article has been cited by other articles:

				T. J Nelson, A. Martinez-Fernandez, and A. Terzic KCNJ11 knockout morula re-engineered by stem cell diploid aggregation Phil Trans R Soc B, January 27, 2009; 364(1514): 269 - 276. [Abstract] [Full Text] [PDF]

				M. R. Barron, N. S. Belaguli, S. X. Zhang, M. Trinh, D. Iyer, X. Merlo, J. W. Lough, M. S. Parmacek, B. G. Bruneau, and R. J. Schwartz Serum Response Factor, an Enriched Cardiac Mesoderm Obligatory Factor, Is a Downstream Gene Target for Tbx Genes J. Biol. Chem., March 25, 2005; 280(12): 11816 - 11828. [Abstract] [Full Text] [PDF]

				J. M. Miano, N. Ramanan, M. A. Georger, K. L. de Mesy Bentley, R. L. Emerson, R. O. Balza Jr., Q. Xiao, H. Weiler, D. D. Ginty, and R. P. Misra Restricted inactivation of serum response factor to the cardiovascular system PNAS, December 7, 2004; 101(49): 17132 - 17137. [Abstract] [Full Text] [PDF]